FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Dermatology
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,342)
Research Grants
(12)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Fear of progression in patients with low-risk malignant melanoma (2017)
Wagner T, Augustin M, Blome C, Forschner A, Garbe C, Gutzmer R, Hauschild A, et al.
Conference contribution
Inhibited Arginase-1 Expression by Fra-1 in Myeloid Cells Enhance Rheumatoid Arthritis Inflammation (2017)
Hannemann N, Schnelzer A, Jordan J, Eberhardt M, Schleicher U, Uebe S, Ekici AB, et al.
Conference contribution
Autologous whole tumor cell-based vaccines generated with high hydrostatic pressure bear immunogenic potential and act synergistically with radiotherapy to retard tumor growth (2017)
Frey B, Seitz C, Weiss EM, Rueckert M, Schlücker E, Schaft N, Fietkau R, Gaipl U
Conference contribution
CAR/TCR-transfected gamma/delta T cells for immunotherapy of melanoma (2017)
Harrer DC, Simon B, Fujii S, Shimizu K, Uslu U, Schoch L, Schuler G, et al.
Conference contribution
A systems biology approach to characterize the function of miRNAs in dendritic cell-mediated immunogenicity and therapeutic cancer vaccination (2017)
Lai X, Dreyer F, Jaitly T, Gerer KF, Schuler G, Dörrie J, Schaft N, Vera J
Conference contribution
BRAF and MEK inhibitors influence human immune cell phenotype and function (2017)
Hoyer S, Eberlein V, Babalija L, Gerer KF, Walter L, Schuler G, Schaft N, et al.
Conference contribution
Secukinumab Treatment of moderate to severe Plaque Psoriasis in the clinical Routine Care: Baseline Data from the PROSPECT Study on Psoriasis Pre-treatment (2017)
Von Kiedrowski R, Korber A, Kraehn-Senftleben G, Sticherling M, Lange L, Bachhuber T, Kasparek TR, et al.
Conference contribution
Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without previous Systemic Therapy for Improvement of Skin Symptoms: PASI and IGA mod. 2011-Results of the PRIME Study (2017)
Reich K, Mrowietz U, Augustin M, Thaci D, Kneidl J, Hentschke C, Simang M, et al.
Conference contribution
Secukinumab is superior to Fumaric Acid Esters in the Treatment of Patients with moderate to severe Plaque Psoriasis without prior System Therapy with respect to the Improvement of quality of life: DLQI and SF-36 Results of the PRIME Study (2017)
Augustin M, Thaci D, Reich K, Mrowietz U, Kneidl J, Hentschke C, Simang M, et al.
Conference contribution
The delivery of antigens to dendritic cells is a potent futureoption for anti-tumor therapies (2017)
Lehmann C, Heger L, Neubert K, Harzer C, Amon L, Yamazaki S, Heidkamp GF, et al.
Conference contribution
‹
1
...
99
100
101
102
103
...
127
›